Nuclease-Resistant Aptamers to Botox and Anthrax Toxins

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$99,913.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI058561-01
Agency Tracking Number:
AI058561
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
OPERATIONAL TECHNOLOGIES CORPORATION
OPERATIONAL TECHNOLOGIES CORPORATION, 4100 N.W. LOOP 410, SAN ANTONIO, TX, 78229
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
JOHN Bruno
(210) 731-0015
JOHN.BRUNO@OTCORP.COM
Business Contact:
NAOMI ALVARADO
(210) 731-0000
NALVARADO@OTCORP.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by investigator): Botulinum toxin and anthrax are two likely bioweapons of choice in military attacks or terrorism against the United States. As such, effective post-exposure therapies, such as antitoxins, to both agents are requir

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government